tiprankstipranks
Trending News
More News >
Akebia Therapeutics’ Growth Potential Driven by Vafseo’s Market Expansion and Upcoming VALOR Trial
PremiumRatingsAkebia Therapeutics’ Growth Potential Driven by Vafseo’s Market Expansion and Upcoming VALOR Trial
30d ago
Akebia Therapeutics: Strong Financial Performance and Promising Growth Prospects Drive Buy Rating
Premium
Ratings
Akebia Therapeutics: Strong Financial Performance and Promising Growth Prospects Drive Buy Rating
2M ago
Akebia Therapeutics Reports Strong Q1 2025 Performance
Premium
Company Announcements
Akebia Therapeutics Reports Strong Q1 2025 Performance
2M ago
Akebia initiated with an Outperform at Leerink
PremiumThe FlyAkebia initiated with an Outperform at Leerink
2M ago
Strategic Developments and Market Opportunities Drive Buy Rating for Akebia Therapeutics
Premium
Ratings
Strategic Developments and Market Opportunities Drive Buy Rating for Akebia Therapeutics
3M ago
Akebia announces CHMP positive opinion for XOANACYL
Premium
The Fly
Akebia announces CHMP positive opinion for XOANACYL
3M ago
Morning Movers: Designer Brands jumps, Accenture falls after quarterly results
PremiumThe FlyMorning Movers: Designer Brands jumps, Accenture falls after quarterly results
3M ago
Akebia 25M share Spot Secondary priced at $2.00
Premium
The Fly
Akebia 25M share Spot Secondary priced at $2.00
3M ago
Closing Bell Movers: Five Below up 10% after Q4 beat
Premium
The Fly
Closing Bell Movers: Five Below up 10% after Q4 beat
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100